2cureX AB (publ) (STO:2CUREX)
1.045
-0.065 (-5.86%)
At close: Mar 27, 2026
2cureX AB Market Cap
2cureX AB has a market cap or net worth of 26.23 million as of March 27, 2026. Its market cap has increased by 163.22% in one year.
Market Cap
26.23M
Enterprise Value
n/a
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.05
Market Cap Chart
Since November 24, 2017, 2cureX AB's market cap has decreased from 83.32M to 26.23M, a decrease of -68.51%. That is a compound annual growth rate of -12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 26.23M | 103.31% |
| Dec 30, 2025 | 12.90M | 73.70% |
| Dec 30, 2024 | 7.43M | -79.00% |
| Dec 29, 2023 | 35.38M | -75.34% |
| Dec 30, 2022 | 143.46M | -51.13% |
| Dec 30, 2021 | 293.59M | 19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 69.35M |
| Spago Nanomedical AB | 67.48M |
| AcouSort AB | 62.65M |
| Nanologica AB | 38.43M |
| Modus Therapeutics Holding AB | 36.85M |
| Guard Therapeutics International AB | 29.75M |
| ExpreS2ion Biotech Holding AB | 19.95M |
| Aptahem AB | 14.89M |